Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 17 of Abpro Holdings, Inc.'s SEC filings and found 3 warrant series, 8 convertibles, 1 equity line, 2 S-1 registrations and 3 completed offerings on file for ABPO. The latest dilution event on file is a registration statement on Dec 2, 2025. Analysis updated Sep 28, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
NRSNNeuroSense Therapeutics Ltd. Ordinary Shares
MBIOMustang Bio, Inc.
BIXTBioxytran, Inc.
ONCOOnconetix, Inc.
DCOYDecoy Therapeutics Inc.
CODXCo-Diagnostics, Inc.
BDRXBiodexa Pharmaceuticals plc American Depositary Shs
HCWBHCW Biologics Inc.
REVBRevelation Biosciences, Inc.
ACUTAccustem Sciences Inc.
CLDICalidi Biotherapeutics, Inc.
MDCXMedicus Pharma Ltd. Common Stock
SILOSilo Pharma, Inc.
SXTP60 Degrees Pharmaceuticals, Inc.
VIVSVivoSim Labs, Inc.